![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Zhejiang East-asia Pharmaceutical Co., Ltd. Taizhou Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Trimebutine maleate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-279 - Rev 01
This Chemical Type CEP, issued on March 28, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2182 associated with this CEP further emphasizes